Biology. Agility. Analytics.

Our relentless dedication to accuracy, timeliness and regulatory rigor enables your therapeutic innovations to reach patients faster.

Cinven Completes Majority Investment in BioAgilytix

Cinven Completes Majority Investment in BioAgilytix

Read More

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

    Services Delivered Scientist to Scientist

    Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.

    biomarkers

    Biomarkers

    immunogenicity

    Immunogenicity

    pharmacokinetics

    Pharmacokinetics & Pharmacodynamics (PK/PD)

    cell-based-assays

    Cell-Based Assays

    Solutions Enabled by World-Leading Expertise

    Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for therapeutics innovation.

    biosimilars

    Biosimilars

    gene-therapy

    Gene Therapy

    antibody-drug-conjugates

    Antibody Drug Conjugates (ADCs)

    immuno-oncology

    Immuno-oncology

    Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge
    SCIENCE ON-DEMAND

    Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge

    Assessing humoral immunogenicity is an interesting challenge for adeno-associated virus (AAV)-based gene therapies. While most people are concerned about how to deal with pre-existing antibodies and their impact on cutpoints — such as using total antibody or neutralizing antibodies for inclusion/exclusion, including/excluding based on these results, and a number of other concerns — often times just coming up with the right assay format for measuring these antibodies is overlooked.

    Watch Now

    The Bioagilytix Perspective

    Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.

    resource center

    Visit Resource Center

    global bioanalytical services cro durham boston hamburg

    ADVANCED BIOANALYTICAL LAB FACILITIES TO SUPPORT ALL PHASES OF DRUG DEVELOPMENT.